Client Journeys
From seed-stage risk to Series A valuation
Representative journeys. We focus on the transformation, not just the grant win.
Representative journeys
DiagnosticAI
Healthtech
ChallengeClinical validation pre-raise
StrategyNIH Omnibus + NSF Phase I
ResultNIH Phase II $2.1M, $15M Series A
“The NIH grant changed investor conversations.”
DefenseAI Systems
Dual-Use
ChallengeFirst customer, long sales cycles
StrategyDoD SBIR via DSIP with Phase III plan
Result$2.2M SBIR, $20M Phase III
“They structured Phase I/II with transition in mind.”
GridPower
Cleantech
ChallengeCapital-intensive R&D
StrategyNSF + IRAP + SR&ED
Result$4.9M non-dilutive, $25M Series A
“We raised from a position of strength.”
Ready to build your journey?
15-minute strategy call. We'll tell you if your technology is grant-fundable and which agencies are the best fit.
Book Strategy Review